Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. More
Articles
DraftKings Is Still Burning Through Cash Flow in Its Latest Quarterly Results
DraftKings Is still burning through cash flow in its latest quarterly results. DKNG stock could take another hit if the DraftKings keeps bleeding out cash from its operations as it did in Q4. More
DoorDash’s Results, Outlook Bode Well for DASH Stock
The valuation of DASH stock is quite reasonable, and the company has grown rapidly in the U.S., making its outlook upbeat. More
Solana May Not be as Insulated as You Might Think
With the Russian invasion of Ukraine, the modern global order has shifted dramatically, boding poorly for Solana and cryptos. More
Novavax: The Frustration Is Real, And So Is the Sales Potential
All isn't well with NVAX stock, but it is very close to rallying. The results could give Novavax a boost and push the stock high. More
What Will Apple Stock Be Worth in 10 Years? A Lot!
Despite Apple’s $2.7 trillion market cap, AAPL stock seems undervalued relative to many S&P 500 stocks. That makes it a long-term buy. More
